
Mirvetuximab Soravtansine
OncoPharm
00:00
Dosing, Naming, and Regulatory Details
John asks about practical prescribing details and covers the drug's name, accelerated approval, boxed toxicity, and dosing basis.
Play episode from 04:42
Transcript


